Rocket


News + Filings
Transactions





TANNENBAUM RENEE P

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
05/23/2023ANI PHARMACEUTICALS INCANIPGrantCommon Stock6.9k$0.00$0 05/23/2023
09/15/2022Cardiff Oncology, Inc.TROVPurchaseCommon Stock3.6k$1.72$6.2k 09/15/2022
09/15/2022Cardiff Oncology, Inc.TROVPurchaseCommon Stock6.4k$1.72$11k 09/15/2022
03/19/2022ANI PHARMACEUTICALS INCANIPGrantCommon Stock13.3k$0.00$0 03/19/2022
03/09/2022Cardiff Oncology, Inc.TROVGrantStock Options26.8k$2.50$67k 03/09/2022
03/07/2022ZOGENIX, INC.ZGNXOtherCommon Stock32.6k$0.00$0 03/07/2022
03/07/2022ZOGENIX, INC.ZGNXDispositionStock Option (Right to Buy)3k$12.80$38.4k 03/07/2022
03/07/2022ZOGENIX, INC.ZGNXDispositionStock Option (Right to Buy)22k$17.83$392.3k 03/07/2022
11/29/2021ZOGENIX, INC.ZGNXSaleCommon Stock5.3k$11.72$62.2k 11/29/2021
06/10/2021Cardiff Oncology, Inc.TROVGrantStock Options44k$7.98$351.1k 06/10/2021
06/01/2021ZOGENIX, INC.ZGNXPurchaseCommon Stock5k$17.05$85.2k 06/01/2021
05/27/2021ZOGENIX, INC.ZGNXGrantStock Option (Right to Buy)22k$17.83$392.3k 05/27/2021
11/17/2020ZOGENIX, INC.ZGNXSaleCommon Stock15k$20.74$311.1k 11/17/2020
05/29/2020ZOGENIX, INC.ZGNXGrantStock Option (Right to Buy)13k$29.13$378.7k 05/29/2020
05/22/2019ZOGENIX, INC.ZGNXGrantStock Option (Right to Buy)13k$39.02$507.3k 05/22/2019
03/06/2019ZOGENIX, INC.ZGNXSaleCommon Stock17.5k$50.65$886.5k 03/06/2019
03/06/2019ZOGENIX, INC.ZGNXExerciseStock Option (Right to Buy)9.4k$10.40$97.5k 03/06/2019
03/06/2019ZOGENIX, INC.ZGNXExerciseStock Option (Right to Buy)6k$12.80$76.8k 03/06/2019
03/06/2019ZOGENIX, INC.ZGNXExerciseStock Option (Right to Buy)20k$8.99$179.8k 03/06/2019
03/06/2019ZOGENIX, INC.ZGNXExerciseStock Option (Right to Buy)20k$12.75$255k 03/06/2019
05/23/2018ZOGENIX, INC.ZGNXGrantStock Option (Right to Buy)15k$41.68$625.2k 05/23/2018
11/21/2013SHARPS COMPLIANCE CORPSMEDGrantRestricted Stock Award11.2k$0.00$0 11/21/2013
11/15/2012SHARPS COMPLIANCE CORPSMEDGrantRestricted Stock Award11.2k$0.00$0 11/15/2012

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy